Hemostatic fibers and strands
View Patent ↗A hemostatic device for promoting the clotting of blood includes a gauze substrate, a clay material disposed on the gauze substrate, and also a polyol such as glycerol or the like disposed on the gauze substrate to bind the clay material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood emanating from the wound to cause the clotting. A bandage that can be applied to a bleeding wound to promote the clotting of blood includes a flexible substrate and a gauze substrate mounted thereon. The gauze substrate includes a clay material and a polyol. A hemostatic sponge also includes a gauze substrate and a dispersion of hemostatic material and a polyol on a first surface of the substrate.
1. A hemostatic device for promoting the clotting of blood comprising:
a plurality of strands;
a hemostatic material comprising kaolin applied to the plurality of strands;
a glycerol binder configured to retain the hemostatic material to the plurality of strands;
wherein the hemostatic device is substantially dry;
wherein the plurality of strands and the hemostatic material initially exist separately from each other; and
wherein the device is configured such that when exposed to blood from a portion of a human body, the hemostatic material to comes into contact with the blood to assist in accelerating clotting.
2. The hemostatic device of claim 1 , wherein the plurality of strands are configured to include interstices between at least some of the plurality of strands.
3. The hemostatic device of claim 1 , wherein the plurality of strands are formed into a gauze.
4. The hemostatic device of claim 1 , wherein the plurality of strands is flexible to allow the device to form to a shape of the bleeding wound and to retain a shape of the bleeding wound.
5. The hemostatic device of claim 1 , wherein the kaolin comprises particles having diameters of less than about 0.2 mm.
6. The hemostatic device of claim 1 , wherein the binder is applied to the strands by a spraying process.
7. The hemostatic device of claim 1 , wherein the binder and the hemostatic material are applied to the strands by a spraying process.
8. The hemostatic device of claim 1 , wherein the binder is applied to the strands by immersing the strands in a liquid comprising the binder.
9. The hemostatic device of claim 3 , wherein the gauze comprises woven strands.
10. The hemostatic device of claim 1 , wherein the binder and the hemostatic material are applied to the strands by a slot-die technique.
11. A hemostatic device for promoting the clotting of blood comprising:
a plurality of strands;
a hemostatic material comprising kaolin applied to the plurality of strands, the strands being formed before the hemostatic material is applied to the strands;
a binder configured to retain the hemostatic material to the plurality of strands;
wherein the hemostatic device is subjected to a drying process after the hemostatic material is applied to the plurality of strands; and
wherein the device is configured such that when applied to a portion of a human body with blood, application of the device is capable of causing blood to contact at least a portion of the plurality of strands, causing at least a portion of the hemostatic material to come into contact with the blood to assist in accelerating clotting.
12. The hemostatic device of claim 11 , wherein the plurality of strands are configured to include interstices between at least some of the plurality of strands.
13. The hemostatic device of claim 11 , wherein the plurality of strands are incorporated into a woven or non-woven material.
14. The hemostatic device of claim 11 , wherein the plurality of strands is flexible to allow the device to form to a shape of the bleeding wound and to retain a shape of the bleeding wound.
15. The hemostatic device of claim 11 , wherein the binder comprises one or more of the following: chitosan, guar gum, gelatinized starches, cellulose, carboxymethylcellulose, a glycerol, polyvinyl alcohol, and calcium alginate.
16. The hemostatic device of claim 11 , wherein the kaolin comprises particles having diameters of less than about 0.2 mm.
17. The hemostatic device of claim 11 , wherein the binder is applied to the strands by a spraying process.
18. The hemostatic device of claim 11 , wherein the binder and the hemostatic material are applied to the strands by a spraying process.
19. The hemostatic device of claim 11 , wherein the binder is applied to the strands by immersing the strands in a liquid comprising the binder.
20. The hemostatic device of claim 11 , wherein the binder and the hemostatic material are applied to the strands by immersing the strands in a liquid comprising the binder and the hemostatic material.
21. The hemostatic device of claim 11 , wherein the binder and the hemostatic material are applied to the strands by a slot-die technique.
22. A hemostatic device comprising:
a fibrous material comprising a plurality of strands;
a clay material applied to at least a portion of the plurality of strands; and
a calcium alginate binder binding the clay material to the plurality of strands; and
wherein the device is substantially dry and is configured such that when treating bleeding, application of the device is capable of causing at least a portion of the clay material to come into contact with blood from a bleeding wound to assist in accelerating clotting.
23. The hemostatic device of claim 22 , wherein the clay material is positioned so as to be exposed on at least two sides of the fibrous material.
24. The hemostatic device of claim 22 , wherein the clay material comprises kaolin or kaolinite.
25. The hemostatic device of claim 22 , wherein the clay material is selected from the group consisting of attapulgite, bentonite, kaolin, kaolinite, and combinations of the foregoing materials.
26. A hemostatic device comprising:
a fibrous material;
a hemostatic material comprising kaolin; and
a binder applied to the fibrous material to bind the hemostatic material to the fibrous material, wherein the binder and the hemostatic material are applied by spraying, immersion, or a slot-die technique; and
wherein the device is configured such that when treating bleeding, application of the device is capable of causing blood to be absorbed within the device and of causing at least a portion of the hemostatic material to come into contact with blood to assist in accelerating clotting.
27. The hemostatic device of claim 26 , wherein the binder comprises glycerol.
28. The hemostatic device of claim 26 , wherein the binder comprises calcium alginate.
29. The hemostatic device of claim 26 , wherein the fibrous material is subjected to a drying process.